Neuland Laboratories to open Hyderabad commercial peptide facility
The CDMO’s Module 1 commercial production module is expected to be operational by summer 2026.
List view / Grid view
Dominic Tyer is the Editor of European Pharmaceutical Review. You can connect with him at LinkedIn or follow him on Bluesky.
The CDMO’s Module 1 commercial production module is expected to be operational by summer 2026.
She joins the Madrid-headquartered contract development and manufacturing organisation from SHL Medical.
The two CDMOs sign an alliance to offer an integrated early-development offering and accelerated commercial pathway.
The collaboration covers the essential medicine's active pharmaceutical ingredients (APIs) and finished doses.
The CDMO is also building a new US aseptic clinical production facility in Illinois as it expands its global footprint.
The CDMO and CRO’s Swedish API facility will now operate as a Nanologica subsidiary, reverting to its original name Syntagon.
He joins the Swedish CDMO from medical device company Dignitana.
The French start-up focuses on advancing rapid microbiology in manufacturing quality control.
General Manager Brian Morrissey discusses his company’s acquisition of fellow Beta-Lactam manufacturer Athlone Laboratories and its implications for an evolving industry.
The cell therapy-focused CDMO has also elevated Melodie Bryce to Chief Quality Officer and Matt Haines to Chief Operations Officer.
As vaccines are buffeted by political pressures, the CDMO discussed its growth approach and some of its key collaborations.
But the sector’s digital transformation ambitions within their quality functions have only been partially realised.
Named CEO of the Year at CPHI Frankfurt, the CDMO's head talks about the type of company he and his team are building.
Gains access to the company’s small molecule-targeted protein degraders to expand its oncology pipeline.
The obesity drug’s new formulation gains an important opportunity to define the market before regulators finish assessing Lilly’s rival orforglipron.